Pharmaceutical Contract Manufacturer, Distributor & Exporter India | NavXport

Pharmaceuticals Contract Manufacturing & Global Wholesale Exporter

NavXport Worldwide LLP delivers vertically integrated chemical production, specialized bulk distribution, and verified transoceanic transport layout pathways for multi-market procurement campaigns.

Regulatory Framework: WHO-GMP Compliant Facilities
Therapeutic Matrix: 50+ Specialized Small-Molecule TKIs & Monoclonal Antibodies
Cold-Chain Controls: Validated 2°C to 8°C Transit Integrity Logs
Global Transit Gateways: Direct Freight Routing via Major Indian Maritime & Air Hubs
Pharmaceutical contract manufacturer distributor exporter India NavXport

Strategic Sourcing, Contract Blending & Global Wholesale Distribution

As an agile, goal-driven trade intermediary and contract manufacturing manager, NavXport Worldwide LLP bridges critical supply gaps for life-saving therapeutics, targeted solid orals, and advanced biosimilars. Our operations coordinate with certified manufacturing facilities throughout major chemical and formulation clusters in India to guarantee high-purity production to exact buyer parameters. From small-molecule targeted therapies to rigorous cold-chain monoclonal antibodies, we offer complete oversight across production validation, global regulatory filings, and containerized maritime and air dispatch systems.

Advanced Contract Manufacturing & Formulation Services

  • Therapeutic Delivery Modalities: Scaled blending for tablets, hard/soft gelatin capsules, multi-dose vials, pre-filled syringes (PFS), and sterile lyophilized injection powders.
  • Oncology & TKI Specialization: High-containment processing paths for cytotoxic oral solids and critical tyrosine kinase inhibitors matching strict batch-to-batch assay parameters.
  • Private-Label Customization: Tailored formulation strengths, multi-lingual secondary carton layouts, anti-counterfeit serialization, and robust primary packaging designs.
  • Regulatory & Validation Frameworks: Dossier support including complete batch manufacturing records (BMR), stability data logs, and active impurity threshold monitoring.
  • Analytical Quality Verification: State-of-the-art laboratory confirmation including high-performance liquid chromatography (HPLC) and heavy metal screening via ICP-MS systems.
  • Global Promotion Compliance: Active execution through Ministry of Health tender frameworks and official integration with Pharmexcil standards for international clearance.

Targeted Oral Solids

Full commercial manufacturing capability for small-molecule tyrosine kinase inhibitors (TKIs). Supplying active molecules like Imatinib, Gefitinib, Erlotinib, Sorafenib, and advanced third-generation Osimertinib or Lenvatinib matrices designed to resolve critical treatment deficits.

Biologics & Cold-Chain

Advanced temperature-tracked monoclonal antibody biosimilars including Rituximab, Bevacizumab, and Trastuzumab. Validated cold-chain handling protocols ensure structural molecular integrity is fully maintained across transoceanic freight pathways.

Hormonal & Cytotoxics

Comprehensive endocrine panel and support formulations including high-volume maintenance oral solids like Enzalutamide, Abiraterone Acetate, and Letrozole, paired with critical adjunctive therapeutics such as Lenalidomide and Capecitabine.

Specialized Therapeutic Categories

Explore our expanded institutional supply lines covering high-containment life-saving medications, critical organ management, and specialized therapeutics.

Chronic Liver Disease

Comprehensive medical portfolio supporting Wilson’S Disease, Chronic Hepatitis B, Chronic Hepatitis C, Pbc (Primary Biliary Cholangitis), and Aih (Autoimmune Hepatitis) pathways.

Blood Plasma Derived Products

PDMPs products such as albumin, coagulation factors, and immunoglobulins, which are life-saving therapeutics optimized for global clinical transit compliance.

Cytotoxic Drugs

High-containment formulations covering Oncology, Monoclonal Antibodies, Nibs (Tyrosine Kinase Inhibitors), and specialized core oncology segment therapeutics.

Anticoagulants

Anticoagulants coming in many different forms, including targeted clinical injections, intravenous (IV) drugs, and high-volume maintenance medications taken by mouth.

Transplants Medications

Critical care management lines providing Organ Preservation Solutions, Immunomodulators, Liver/Kidney specific support, and BMT (Bone Marrow Transplant) clinical supplies.

Other Pharmaceutical Products

Extended structural completer panel providing Anesthetics, Anti-Diabetic therapies/Insulins, HIV/AIDS therapeutics, systemic Immunomodulators, and Infertility treatments.

Institutional Sourcing Gateway

Search our global pharmaceutical database. If a specialized molecule or clinical formulation is unlisted, our procurement desk will issue a rapid compliance quote.

Strategic Export Portfolio & Reference Marks

Comprehensive structural view of active therapeutic lines managed under NavXport Worldwide LLP’s international distribution framework, matching the exact molecules specified in NavXport Worldwide LLP – Oncology Export Portfolio.pdf.

1. Small-Molecule Tyrosine Kinase Inhibitors & Targeted Oral Solids

Generic Molecule & Strengths Available Forms / Reference Generic Marks Portfolio Tier Status
Imatinib (100mg/400mg)Capsules & Tablets (Veenat, Imatikast Equivalent)CORE MARKET SUPPLY
Gefitinib (250mg)Tablets (Geftib, Gefticip, Geffy Equivalent)CORE MARKET SUPPLY
Erlotinib (100mg/150mg)Tablets (Erlocip, Erlonat Equivalent)CORE MARKET SUPPLY
Nintedanib (100mg/150mg)Soft Gelatin Capsules (Cyendiv, Nintib Equivalent)CORE MARKET SUPPLY
Ribociclib (200mg)Tablets (Kryxana Equivalent)CORE MARKET SUPPLY
Ceritinib (150mg)Capsules (Noxalk Equivalent)CORE MARKET SUPPLY
Ibrutinib (140mg)Capsules (Nitib Equivalent)CORE MARKET SUPPLY
Sorafenib (100mg)Tablets (Sorafenat Equivalent)CORE MARKET SUPPLY
Regorafenib (40mg)Tablets (Regonat Equivalent)CORE MARKET SUPPLY
Dasatinib (20mg)Tablets (Dasanat Equivalent)CORE MARKET SUPPLY
Lapatinib (250mg)Tablets (Herduo Equivalent)CORE MARKET SUPPLY
Osimertinib (40mg/80mg)Solid Oral Matrix (Third-Gen EGFR Line)CORE MARKET SUPPLY
Lenvatinib (4mg/10mg)Oral Capsules (Hepatocellular Segment)CORE MARKET SUPPLY
Cabozantinib (20mg/40mg/60mg)Targeted Oral Solids (Renal Care Deficit)CORE MARKET SUPPLY
Venetoclax (10mg/50mg/100mg)Solid Oral Delivery (B-Cell Lymphoma Line)CORE MARKET SUPPLY
Alectinib (150mg)Stabilized Oral Capsules (ALK-Positive)CORE MARKET SUPPLY
Pazopanib (200mg/400mg)Solid Oral Tablets (Sarcoma Infrastructure)CORE MARKET SUPPLY
Ruxolitinib (5mg/15mg/20mg)Orphan Myelofibrosis Oral Solid LinesCORE MARKET SUPPLY

2. Advanced Monoclonal Antibodies & Biologics

Generic Biologic Molecule Standard Export Presentation Portfolio Tier Status
Rituximab Biosimilar100mg/500mg Single-Dose VialsCOLD-CHAIN VERIFIED 2°C TO 8°C
Bevacizumab Biosimilar100mg/400mg Temperature-Tracked VialsCOLD-CHAIN VERIFIED 2°C TO 8°C
Trastuzumab Biosimilar150mg/440mg Lyophilized Multi-Dose VialsCOLD-CHAIN VERIFIED 2°C TO 8°C
Denosumab Alternative60mg/120mg Pre-filled Syringes (PFS)COLD-CHAIN VERIFIED 2°C TO 8°C
Bortezomib for Injection2mg/3.5mg Sterile Lyophilized Powder VialsCOLD-CHAIN VERIFIED 2°C TO 8°C

3. Hormonal Modulators & Anti-Androgens

Generic Molecule & Strengths Available Forms / Reference Generic Marks Portfolio Tier Status
Enzalutamide (40mg)Soft Capsules / Tablets (Xtandi, Xylutide Equivalent)CORE MARKET SUPPLY
Abiraterone Acetate (250mg)Tablets (Abirapro, Xbira, Abirakast Equivalent)CORE MARKET SUPPLY
Letrozole (2.5mg)Tablets (Letronate Equivalent)CORE MARKET SUPPLY
Anastrozole (1mg)Tablets (Altraz Equivalent)CORE MARKET SUPPLY
Fulvestrant250mg/5mL Advanced Pre-filled SyringesCORE MARKET SUPPLY
Tamoxifen Citrate (10mg/20mg)High-Volume Maintenance Oral SolidsCORE MARKET SUPPLY
Bicalutamide (50mg)Prostate Gland Solid Oral FormulationsCORE MARKET SUPPLY
Exemestane (25mg)Endocrine Panel Oral Structural CompleterCORE MARKET SUPPLY

4. Immunomodulators, Cytotoxics & Supportive Care

Generic Molecule & Strengths Available Forms / Reference Generic Marks Portfolio Tier Status
Lenalidomide (10mg)Capsules (Lenangio, Lenalid Equivalent)CORE MARKET SUPPLY
Thalidomide (50mg/100mg)Capsules (Thalix, Thycad Equivalent)CORE MARKET SUPPLY
Zoledronic Acid (4mg)Injection/100ml Infusion (Zoldonat, Natzold)CORE MARKET SUPPLY
Sirolimus (2mg)Tablets (Siroboon Equivalent)CORE MARKET SUPPLY
Tretinoin (10mg)Capsules (Vesanoid Equivalent Acute Line)CORE MARKET SUPPLY
Capecitabine (500mg)Tablets (Cacit Systemic Equivalent)CORE MARKET SUPPLY
Etoposide (50mg)Capsules (Etovel Oral Form Variant)CORE MARKET SUPPLY
Chlorambucil (5mg)Tablets (Clokeran Stable Oral Formulation)CORE MARKET SUPPLY
Aprepitant (Apracap)Capsules (Chemotherapy Emesis Support Element)CORE MARKET SUPPLY

Technical Validation Parameters

Standard parameters for analytical testing, validation frameworks, and stability controls conducted across our generic and biosimilar export lines.

Product Classification Target Validation Framework Primary Analytical Testing Method
Small-Molecule TKIs Active Assay ≥ 98.5–101.5% | Single Impurity < 0.1% High-Performance Liquid Chromatography (HPLC) / UV Verification
Advanced Biosimilars Glycosylation Mapping | Structural Conformation Profile Capillary Electrophoresis / SEC-HPLC Temperature Integrity Tracking
Hormonal Solid Formulations Uniform Dissolution Kinetics | Dissolution Profile Stability USP Apparatus II (Paddle Method) / Wet Chemistry Lot Control
Cytotoxic Injectables Sterility Assurance Level (SAL) 10⁻⁶ | Endotoxin Screening Limulus Amebocyte Lysate (LAL) Kinetic Chromogenic Testing

Packaging

Solid oral dosage matrices are sealed in thermoformed aluminum-aluminum or PVC-PVDC blister strips and housed in export-grade tempered security cartons with tamper-evident seals. Advanced monoclonal antibodies and lyophilized biological injectables are packed in USP Type I borosilicate glass vials enclosed within multi-layer thermal insulation configurations. Standard air and ocean freight container loadability provides optimized volume configurations for temperature-controlled units achieving full volumetric utilization up to twenty-four metric tons per container. Palletized shipments are secured on heat-treated ISPM-15 compliant pallets wrapped in heavy-gauge multi-layer protective thermal films to eliminate moisture or temperature variances.

Export Focus

Core target global procurement markets include North America, Western Europe, the United Kingdom, Central and West Africa, Latin America, and the Middle East. Comprehensive ocean and air freight transit insurance is strictly executed under Institute Cargo Clauses A All-Risks provisions for full commercial value protection. Standard manufacturing and shipping lead times range between fifteen and twenty-five days following institutional trade finance verification or letter of credit activation. Full international trade compliance is maintained via automated digital documentation stacks containing lot-specific certificates of analysis, clean bills of lading, and Pharmexcil regulatory clearances.

NavXport Global Sourcing Advantage vs Competitors

While reputable alternative trade facilitators historically distribute specialty pharmaceutical ranges out of standard regional centers, NavXport Worldwide LLP updates procurement through deep technological integration and end-to-end containerized tracking. Our goal-driven structure moves us rapidly into the top 5% of global pharmaceutical export networks by solving complex multi-market supply crises with immediate regulatory execution and clear financial frameworks.

Top 5% Strategic Milestones

By managing direct contract placement lines with India’s leading chemical and pharmaceutical manufacturing campuses (such as Intas, Natco, Biocon, and Sun Pharma), NavXport bypasses traditional intermediary bottlenecks. This guarantees absolute compliance with international heavy metal limits, strict GHS safety protocols, and robust multi-modal freight logistics under Institute Cargo Clauses (A) insurance frameworks.

Frequently Asked Questions

Review standard technical, logistical, and commercial terms governing international institutional pharmaceutical procurement.

What pharmaceutical supply capabilities does NavXport Worldwide LLP offer?
NavXport Worldwide LLP provides comprehensive contract manufacturing, global wholesale distribution, and regulatory export services for specialty pharmaceuticals and general medicine formulations.
Which regulatory certifications back your pharmaceutical manufacturing facilities in India?
Our partner manufacturing sites operate in strict compliance with WHO-GMP, ISO 9001:2015, and international regulatory frameworks ensuring global quality standards.
What oncology molecules are currently active in your small-molecule portfolio?
Our core active portfolio includes targeted small-molecule tyrosine kinase inhibitors such as Imatinib, Gefitinib, Erlotinib, Nintedanib, Sorafenib, and third-generation Osimertinib.
Do you supply advanced monoclonal antibodies and biological therapies?
Yes, we export cold-chain verified biosimilars including Rituximab, Bevacizumab, and Trastuzumab in lyophilized multi-dose and single-dose vial presentations.
What temperature tracking mechanisms are used for biological shipments?
All advanced biologics are shipped inside validated passive or active thermal containers equipped with continuous digital data loggers tracking the 2°C to 8°C spectrum.
Can institutional buyers request custom private-label contract manufacturing?
Yes, we provide end-to-end contract manufacturing with customizable formulation strengths, private branding, multi-lingual secondary packaging, and tailored blister configurations.
What documentation is provided with every pharmaceutical export consignment?
Every shipment includes a lot-specific Certificate of Analysis, GHS-compliant Safety Data Sheet, Certificate of Origin, Commercial Invoice, Packing List, and clear Bill of Lading.
Are your products compliant with international heavy metal and impurity thresholds?
Yes, all formulations undergo advanced analytical validation including ICP-MS tracking for heavy metals to guarantee compliance with global pharmacopeia limits.
Do you participate in international ministry of health and institutional tenders?
Yes, NavXport acts as a qualified technical sourcing intermediary and direct bidder for municipal, institutional, and sovereign health ministry pharmaceutical tenders.
What is your active operational footprint for global distribution?
We actively manage distribution networks spanning North America, Western Europe, the United Kingdom, Africa, the Middle East, Asia, and Latin America.
Do you manage special supply pathways such as Named Patient Programs?
Yes, we provide dedicated documentation assistance and logistics architecture to support Named Patient Supplies, Managed Access Programs, and Early Access pathways.
What oral solid hormonal modulators are available in your strategic portfolio?
Our endocrine panel includes high-volume maintenance oral solids such as Enzalutamide, Abiraterone Acetate, Letrozole, Anastrozole, and Bicalutamide.
What support do you offer for product technology transfers and dossier dossiers?
We supply comprehensive technical documentation packs, batch manufacturing records, stability data summaries, and active pharmaceutical ingredient master file references.
Which Indian maritime and air ports do you utilize for global dispatches?
We execute rapid export dispatches via primary logistical gateways including Mundra Port, Nhava Sheva JNPT, and international air cargo terminals in Mumbai and Delhi.
What are your standard trade finance and payment structures for institutional buyers?
We operate under irrevocable Letters of Credit at sight, structured documents against payment, or negotiated telegraphic transfer milestones matched to verified production lots.
How does NavXport ensure the security of high-value oncology shipments against counterfeiting?
All secondary packaging incorporates advanced security features including serialized QR codes, tamper-evident structural seals, and holographic authentication markers.
What supportive care and cytotoxic adjunct formulations are available?
Our portfolio supplies critical supportive therapies including Lenalidomide, Zoledronic Acid infusions, Capecitabine, and Aprepitant anti-emesis capsules.
Do you support cold-chain logistics for deep-freeze or specialized temperature criteria?
Yes, our logistics infrastructure handles ultra-low temperature, deep-freeze, or custom climate envelopes via qualified cold-chain carrier alliances.
Is NavXport Worldwide LLP a registered member of Indian export promotion councils?
Yes, NavXport maintains active membership status with Pharmexcil and operates under official import-export code authorizations granted by the Government of India.
What are the standard lead times for manufacturing bulk generic orders?
Commercial production campaigns typically average fifteen to twenty-five days from technical dossier approval and payment execution to final port dispatch clearance.

Technical Dossiers & Export Catalogs

Access validated chemistry assays, product safety summaries, and manufacturing capabilities documentation.

Request Dossier & Portfolio PDF *PDF Document Format | Includes full reference parameters to NavXport Worldwide LLP – Oncology Export Portfolio.pdf

Connect with Our Pharmaceutical Export Desk

Initiate a formal commercial inquiry or request pricing lists for custom contract manufacturing campaigns.

NavXport Corporate Sourcing Desk

Operational Business Schedule: Monday – Saturday | 09:00 – 19:00 IST
© 2026 NavXport Worldwide LLP. All Rights Reserved. Strategic global pharma contract routing framework.
Home » Pharmaceutical Contract Manufacturer, Distributor & Exporter, India